Siltuximab
Category: CancerSiltuximab Overview
Siltuximab (INN, trade name Sylvant; also known as CNTO 328, anti-IL-6 chimeric monoclonal antibody or cCLB8) is a chimeric (made from human and mouse proteins) monoclonal antibody. It binds to interleukin-6.[1][2] Siltuximab has been investigated for the treatment of neoplastic diseases:[3] metastatic renal cell cancer,[4] prostate cancer,[5] and Castleman's disease,[6][7] among ot...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Siltuximab
Recent Siltuximab Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Siltuximab
- Injection: 100mg, 400mg
Other drugs which contain Siltuximab or a similar ingredient: (1 result)
- SYLVANT Siltuximab